Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Arl8a | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Arl8a (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARL8A mRNA | CTD | PMID:36331819 | Arl8a | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Arl8a (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARL8A mRNA | CTD | PMID:22206623 | Arl8a | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Arl8a (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of ARL8A mRNA | CTD | PMID:22206623 | Arl8a | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of ARL8A mRNA | CTD | PMID:25380136 | Arl8a | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | ARL8A (Homo sapiens) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ARL8A protein | CTD | PMID:31675489 | Arl8a | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | ARL8A (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARL8A mRNA | CTD | PMID:22298810 | Arl8a | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Arl8a (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARL8A mRNA | CTD | PMID:21570461|PMID:24680724 | Arl8a | Rat | 2,4,6-tribromophenol | decreases expression | ISO | ARL8A (Homo sapiens) | 6480464 | 2,4,6-tribromophenol results in decreased expression of ARL8A mRNA | CTD | PMID:31675489 | Arl8a | Rat | 2-hydroxypropanoic acid | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of ARL8A mRNA | CTD | PMID:30851411 | Arl8a | Rat | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | ARL8A (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of ARL8A protein | CTD | PMID:31675489 | Arl8a | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ARL8A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Arl8a | Rat | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Arl8a (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of ARL8A mRNA | CTD | PMID:18648102 | Arl8a | Rat | actinomycin D | multiple interactions | ISO | ARL8A (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of ARL8A mRNA | CTD | PMID:38460933 | Arl8a | Rat | aflatoxin B1 | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of ARL8A mRNA | CTD | PMID:21632981|PMID:21641981 | Arl8a | Rat | all-trans-retinoic acid | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ARL8A mRNA | CTD | PMID:33167477 | Arl8a | Rat | aristolochic acid A | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of ARL8A mRNA | CTD | PMID:33212167 | Arl8a | Rat | benzo[a]pyrene | increases expression | ISO | Arl8a (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of ARL8A mRNA | CTD | PMID:22228805 | Arl8a | Rat | benzo[a]pyrene | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ARL8A mRNA | CTD | PMID:20106945|PMID:21632981|PMID:26238291 | Arl8a | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ARL8A mRNA | CTD | PMID:26238291 | Arl8a | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Arl8a (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of ARL8A mRNA | CTD | PMID:34319233 | Arl8a | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ARL8A mRNA | CTD | PMID:25181051 | Arl8a | Rat | bisphenol A | increases expression | ISO | Arl8a (Mus musculus) | 6480464 | bisphenol A results in increased expression of ARL8A mRNA | CTD | PMID:35479511 | Arl8a | Rat | bisphenol A | decreases methylation | ISO | ARL8A (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of ARL8A gene | CTD | PMID:31601247 | Arl8a | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ARL8A mRNA | CTD | PMID:30816183|PMID:34947998 | Arl8a | Rat | bisphenol F | multiple interactions | ISO | ARL8A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Arl8a | Rat | bortezomib | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Bortezomib results in increased expression of ARL8A mRNA | CTD | PMID:20977926 | Arl8a | Rat | Butylbenzyl phthalate | increases methylation | ISO | Arl8a (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of ARL8A intron | CTD | PMID:28392331 | Arl8a | Rat | cadmium dichloride | decreases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of ARL8A mRNA | CTD | PMID:38568856 | Arl8a | Rat | choline | multiple interactions | ISO | Arl8a (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Arl8a | Rat | cisplatin | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ARL8A mRNA | CTD | PMID:27392435 | Arl8a | Rat | clozapine | decreases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Clozapine results in decreased expression of ARL8A protein | CTD | PMID:34122009 | Arl8a | Rat | cobalt dichloride | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of ARL8A mRNA | CTD | PMID:19320972 | Arl8a | Rat | copper(II) sulfate | decreases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ARL8A mRNA | CTD | PMID:19549813 | Arl8a | Rat | cyclosporin A | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ARL8A mRNA | CTD | PMID:20106945|PMID:21632981|PMID:25562108 | Arl8a | Rat | decabromodiphenyl ether | decreases expression | ISO | ARL8A (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of ARL8A protein | CTD | PMID:31675489 | Arl8a | Rat | dexamethasone | multiple interactions | ISO | ARL8A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Arl8a | Rat | doxorubicin | decreases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ARL8A mRNA | CTD | PMID:29803840 | Arl8a | Rat | ethanol | affects splicing | ISO | Arl8a (Mus musculus) | 6480464 | Ethanol affects the splicing of ARL8A mRNA | CTD | PMID:30319688 | Arl8a | Rat | ethyl methanesulfonate | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of ARL8A mRNA | CTD | PMID:23649840 | Arl8a | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of ARL8A mRNA | CTD | PMID:24136188 | Arl8a | Rat | folic acid | multiple interactions | ISO | Arl8a (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARL8A mRNA; [Methionine deficiency co-treated more ... | CTD | PMID:20938992|PMID:22206623 | Arl8a | Rat | folic acid | decreases expression | ISO | Arl8a (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ARL8A mRNA | CTD | PMID:25629700 | Arl8a | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ARL8A mRNA | CTD | PMID:33387578 | Arl8a | Rat | GSK-J4 | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | GSK-J4 results in increased expression of ARL8A mRNA | CTD | PMID:29301935 | Arl8a | Rat | indometacin | multiple interactions | ISO | ARL8A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Arl8a | Rat | inulin | multiple interactions | ISO | Arl8a (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ARL8A mRNA | CTD | PMID:36331819 | Arl8a | Rat | ivermectin | decreases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ARL8A protein | CTD | PMID:32959892 | Arl8a | Rat | L-methionine | multiple interactions | ISO | Arl8a (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Arl8a | Rat | lead(0) | affects expression | ISO | ARL8A (Homo sapiens) | 6480464 | Lead affects the expression of ARL8A mRNA | CTD | PMID:28903495 | Arl8a | Rat | methyl methanesulfonate | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of ARL8A mRNA | CTD | PMID:23649840 | Arl8a | Rat | naphthalene | increases expression | ISO | Arl8a (Mus musculus) | 6480464 | naphthalene results in increased expression of ARL8A mRNA | CTD | PMID:18978301 | Arl8a | Rat | Nutlin-3 | multiple interactions | ISO | ARL8A (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of ARL8A mRNA | CTD | PMID:38460933 | Arl8a | Rat | paracetamol | affects expression | ISO | Arl8a (Mus musculus) | 6480464 | Acetaminophen affects the expression of ARL8A mRNA | CTD | PMID:17562736 | Arl8a | Rat | paracetamol | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ARL8A mRNA | CTD | PMID:22230336|PMID:29067470 | Arl8a | Rat | pentachlorophenol | increases expression | ISO | Arl8a (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of ARL8A mRNA | CTD | PMID:23892564 | Arl8a | Rat | perfluorononanoic acid | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of ARL8A mRNA | CTD | PMID:32588087 | Arl8a | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Arl8a (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARL8A mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Arl8a | Rat | phenobarbital | multiple interactions | ISO | Arl8a (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ARL8A mRNA] | CTD | PMID:19482888 | Arl8a | Rat | phenobarbital | increases expression | ISO | Arl8a (Mus musculus) | 6480464 | Phenobarbital results in increased expression of ARL8A mRNA | CTD | PMID:19482888 | Arl8a | Rat | phenobarbital | affects expression | ISO | ARL8A (Homo sapiens) | 6480464 | Phenobarbital affects the expression of ARL8A mRNA | CTD | PMID:19159669 | Arl8a | Rat | rac-lactic acid | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of ARL8A mRNA | CTD | PMID:30851411 | Arl8a | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of ARL8A mRNA | CTD | PMID:28374803 | Arl8a | Rat | rotenone | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Rotenone results in increased expression of ARL8A protein | CTD | PMID:39603559 | Arl8a | Rat | sodium arsenite | affects expression | ISO | ARL8A (Homo sapiens) | 6480464 | sodium arsenite affects the expression of ARL8A mRNA | CTD | PMID:20816728 | Arl8a | Rat | sodium arsenite | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of ARL8A mRNA | CTD | PMID:38568856 | Arl8a | Rat | sunitinib | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Sunitinib results in increased expression of ARL8A mRNA | CTD | PMID:31533062 | Arl8a | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of ARL8A mRNA | CTD | PMID:31150632 | Arl8a | Rat | thiram | increases expression | ISO | ARL8A (Homo sapiens) | 6480464 | Thiram results in increased expression of ARL8A mRNA | CTD | PMID:38568856 | Arl8a | Rat | titanium dioxide | decreases methylation | ISO | Arl8a (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of ARL8A promoter | CTD | PMID:35295148 | Arl8a | Rat | titanium dioxide | increases methylation | ISO | Arl8a (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of ARL8A gene | CTD | PMID:35295148 | Arl8a | Rat | triphenyl phosphate | affects expression | ISO | ARL8A (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of ARL8A mRNA | CTD | PMID:37042841 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















